ArticleBMC health services research2026
Community pharmacists as behavioral health extenders: an effectiveness-implementation hybrid type II feasibility evaluation.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAvailability of mental health services is often limited, with many patients suffering from depression or anxiety either unidentified or unable to access care. Community pharmacists may be well-positioned to serve as behavioral healthcare extenders by offering timely screening, referrals, education, and medication management. However, evidence supporting feasibility and effectiveness of behavioral health (BH) care interventions in community pharmacy settings remains anecdotal. The purpose of this article is to summarize the findings from a feasibility evaluation of a BH intervention in 7 U.S. community pharmacies.
methodsThe BH intervention, delivered over 6-11 months, consisted of a screening and referral program and a 6-session education and medication management program. Participating pharmacies benefited from a multi-faceted implementation strategy (e.g., coaching, toolkits). An effectiveness-implementation hybrid Type II design was used to assess effectiveness of the intervention, while evaluating its implementation. Implementation outcomes involved program adoption rates, levels of program acceptability, appropriateness, and feasibility, intent to sustain, and fidelity rates. Intervention outcomes included: patient referral rates, perceived benefits, and changes in patient knowledge, clinical symptoms, and medication adherence. The data were collected using multiple methods (e.g., surveys, interviews, administrative data) and analyzed accordingly.
resultsResults indicated a 100% adoption rate by the pharmacies with intent to continue past the project period; significant increases in program acceptability, appropriateness, and feasibility; and high levels of program fidelity. All 206 patients were appropriately referred as needed, with patients enrolled in the 6-session program reporting statistically significant changes in knowledge, clinical symptoms, and a nonadherence to medications.
conclusionsThese findings lend support to the role that community pharmacists can play in bridging the mental health care gap and improving population health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.